Mingkai Li

426 total citations
38 papers, 294 citations indexed

About

Mingkai Li is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Mingkai Li has authored 38 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Mingkai Li's work include Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Mingkai Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Hepatitis B Virus Studies (8 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Mingkai Li collaborates with scholars based in China, United States and Taiwan. Mingkai Li's co-authors include Bin Wu, Sizhe Wan, J. Marc Simard, Toby C. Chai, Yan Sun, Yiming Lei, Shuying Chen, Haifang Wang, Hong Wan and Xue Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Urology and Frontiers in Immunology.

In The Last Decade

Mingkai Li

34 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingkai Li China 9 93 75 47 41 40 38 294
Elisa Negri Italy 7 90 1.0× 39 0.5× 75 1.6× 29 0.7× 14 0.3× 15 360
Zhifei Wang China 11 139 1.5× 122 1.6× 9 0.2× 22 0.5× 35 0.9× 41 396
Cui Zhou China 11 146 1.6× 97 1.3× 47 1.0× 9 0.2× 52 1.3× 20 326
Alexander J. Martin United Kingdom 6 183 2.0× 51 0.7× 5 0.1× 35 0.9× 34 0.8× 10 366
Subo Gong China 13 98 1.1× 26 0.3× 6 0.1× 70 1.7× 28 0.7× 34 390
Yusuke Takeda Japan 12 130 1.4× 29 0.4× 7 0.1× 18 0.4× 19 0.5× 27 310
Wenzhao Liang China 9 136 1.5× 60 0.8× 17 0.4× 38 0.9× 38 0.9× 23 314
Hiroki Kittaka Japan 7 101 1.1× 10 0.1× 9 0.2× 42 1.0× 29 0.7× 12 374
Jingyi Guo China 12 246 2.6× 37 0.5× 34 0.7× 47 1.1× 44 1.1× 24 378
Hongchao Cao China 10 200 2.2× 108 1.4× 19 0.4× 11 0.3× 100 2.5× 15 392

Countries citing papers authored by Mingkai Li

Since Specialization
Citations

This map shows the geographic impact of Mingkai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingkai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingkai Li more than expected).

Fields of papers citing papers by Mingkai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingkai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingkai Li. The network helps show where Mingkai Li may publish in the future.

Co-authorship network of co-authors of Mingkai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mingkai Li. A scholar is included among the top collaborators of Mingkai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingkai Li. Mingkai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Chao, Benhong Xu, Yue Hu, et al.. (2025). Designing novel nucleoside inhibitors targeting the allosteric site of PBP2a: A strategic approach to overcome resistance in MRSA. Bioorganic & Medicinal Chemistry. 122. 118133–118133. 2 indexed citations
2.
Li, Mingkai, Zebin Chen, Jianning Chen, et al.. (2025). Interactive Explainable Deep Learning Model for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid–enhanced MRI: A Retrospective, Multicenter, Diagnostic Study. Radiology Imaging Cancer. 7(3). e240332–e240332.
3.
Li, Mingkai, Hao Jiang, Yinan Huang, et al.. (2025). Diagnostic and Prognostic Performance of the Agile 3+ Score in Patients With Chronic Hepatitis B and Concurrent MASLD After Complete Viral Suppression With Nucleos(t)ide Analogues. Journal of Gastroenterology and Hepatology. 40(12). 2963–2975.
4.
5.
Wang, Tianyi, Haimei Chen, Zebin Chen, Mingkai Li, & Yao Lu. (2024). Prediction model of early recurrence of multimodal hepatocellular carcinoma with tensor fusion. Physics in Medicine and Biology. 69(12). 125003–125003. 4 indexed citations
6.
7.
Lin, Weichun, Mingkai Li, Xiao Liu, et al.. (2024). Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients. World Journal of Hepatology. 16(11). 1321–1230.
8.
Huang, Yinan, Mingkai Li, Hao Jiang, et al.. (2024). Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease. Journal of Gastroenterology and Hepatology. 39(10). 2169–2181. 6 indexed citations
9.
Li, Mingkai, et al.. (2024). The fibrosis investigating navigator in diabetes ( FIND ): A tool to predict liver fibrosis risk in subjects with diabetes. Diabetes Obesity and Metabolism. 27(3). 1184–1197. 3 indexed citations
10.
Jiang, Hao, et al.. (2023). Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World Journal of Gastroenterology. 29(35). 5166–5177. 7 indexed citations
11.
12.
13.
Shen, Nian, Yajing Mi, Kai Ren, et al.. (2022). The inhibitory effects of Dulaglutide on cellular senescence against high glucose in human retinal endothelial cells. Human Cell. 35(4). 995–1004. 12 indexed citations
14.
Liu, Yongsheng, et al.. (2022). Pyrancoumarin derivative LP4C targeting of pyrimidine de novo synthesis pathway inhibits MRSA biofilm and virulence. Frontiers in Pharmacology. 13. 959736–959736. 7 indexed citations
15.
Wan, Sizhe, Yiming Lei, Mingkai Li, & Bin Wu. (2021). A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes. Hepatology International. 16(1). 112–124. 38 indexed citations
16.
Li, Mingkai, et al.. (2020). The incidence risk of programmed cell death-1/programmed cell death ligand 1 inhibitor-related alopecia for cancer patients. Medicine. 99(42). e22555–e22555. 2 indexed citations
17.
Shi, Lei, et al.. (2020). Relationship Between Magnetic Resonance T2-Mapping and Matrix Metalloproteinase 1,3 in Knee Osteoarthritis. Indian Journal of Orthopaedics. 55(4). 974–982. 1 indexed citations
18.
Shu, Xin, Jing Li, & Mingkai Li. (2014). Crystal Structure, Photoluminescent and Theoretical Studies of 3-Acetyl-8-methoxy-coumarin Derivatives. Asian Journal of Chemistry. 26(24). 8427–8430. 1 indexed citations
19.
Chang, Kuo-Hao, Mingkai Li, & Hong Wan. (2011). Combining strong and screening designs for large-scale simulation optimization. Winter Simulation Conference. 4127–4138. 2 indexed citations
20.
Li, Mingkai, Yan Sun, J. Marc Simard, & Toby C. Chai. (2011). Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourology and Urodynamics. 30(4). 606–611. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Negri Breakdown of academic impact, for papers by Zhifei Wang Breakdown of academic impact, for papers by Cui Zhou Breakdown of academic impact, for papers by Alexander J. Martin Breakdown of academic impact, for papers by Subo Gong Breakdown of academic impact, for papers by Yusuke Takeda Breakdown of academic impact, for papers by Wenzhao Liang Breakdown of academic impact, for papers by Hiroki Kittaka Breakdown of academic impact, for papers by Jingyi Guo Breakdown of academic impact, for papers by Hongchao Cao
Rankless by CCL
2026